Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Chromatography, High Pressure Liquid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Unspecified Adult Solid Tumor, Protocol Specific 4 Melanoma 4 Prostatic Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lung Neoplasms 2 Hepatitis C 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neurofibrosarcoma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Malignant mesenchymal tumor 1 Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 81 Etoposide 44 Temozolomide 37 Carboplatin 37 Filgrastim 36 Topotecan 35 Melphalan 35 Isotretinoin 35 Irinotecan 35 Vincristine 34 Doxorubicin 33 3-Iodobenzylguanidine 30 Granulocyte Colony-Stimulating Factor 26 Cisplatin 25 Peripheral Blood Stem Cell Transplantation 24 sargramostim 21 dinutuximab 21 Granulocyte-Macrophage Colony-Stimulating Factor 21 Radiotherapy 20 Busulfan 18 fludarabine 16 Magnetic Resonance Spectroscopy 16 naxitamab 14 aldesleukin 13 Thiotepa 13 Interleukin-2 13 fludarabine phosphate 12 humanized 3F8 anti-GD2 monoclonal antibody 11 etoposide phosphate 11 Biopsy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00646230 2023-04-07

IV Fenretinide

Children's Hospital Los Angeles

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡